FSPKF - Fisher & Paykel Healthcare Corporation Limited

Other OTC - Other OTC Delayed price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2022
31/03/2021
31/03/2020
Total revenue
1,457,300
1,642,400
1,948,200
1,273,400
Cost of revenue
574,100
629,000
725,600
427,900
Gross profit
883,200
1,013,400
1,222,600
845,500
Operating expenses
Research development
162,500
154,000
136,700
118,500
Selling general and administrative
405,800
393,100
396,600
338,000
Total operating expenses
668,800
643,100
618,300
517,500
Operating income or loss
214,400
370,300
604,300
328,000
Interest expense
3,700
4,900
5,000
3,900
Total other income/expenses net
3,300
40,200
32,400
-16,800
Income before tax
317,400
504,200
718,200
370,500
Income tax expense
66,400
127,300
194,000
83,200
Income from continuing operations
251,000
376,900
524,200
287,300
Net income
251,000
376,900
524,200
287,300
Net income available to common shareholders
251,000
376,900
524,200
287,300
Basic EPS
-
0.65
0.91
0.50
Diluted EPS
-
0.65
0.90
0.50
Basic average shares
-
576,949
575,650
574,192
Diluted average shares
-
579,846
579,867
579,234
EBITDA
-
605,100
808,200
435,400